NCT02254863
- Conditions
- Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Clinical trial condition
Histiocytosis
Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.
406 public trials
82 recruiting studies
Histiocytosis trial results
NCT07800234
- Conditions
- HLH, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, +4 more
- Locations
-
- Faculty of Medicine Pediatric Hematology Oncology Department Cairo, Egypt
- Faculty of medicine ain shams university Cairo, Egypt
NCT05588167
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05857969
- Conditions
- Bone Marrow Diseases, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +38 more
- Locations
-
- Nicklaus Children's Hospital Miami, Florida, United States
NCT07440290
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom
NCT07570823
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
- IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
- Hospital Beata Maria Ana Madrid, Spain
- Hospital Fundación Jiménez Diaz Madrid, Spain
Recruiting
Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.
NCT07739654
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Mayo Hospital Lahore, Punjab Province, Pakistan
NCT07749365
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Recruiting
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
- Locations
-
- City of Hope Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Bergen New York, United States